Tech Names Reach All-Time Highs while OneMain Falls on Weakening Branch Traffic
Last week, the Opportunity Equity Strategy’s representative account gained 0.27%, underperforming the S&P 500’s 1.98% rise. (Exhibit 1). The strategy ended the week up 10.23% YTD, 704 basis points behind the S&P 500.Exhibit 1: Performance of Opportunity Equity Representative Account Net of Fees, Versus S&P 500, Through 7/5/241
| Time Period | Opportunity Equity Representative Account | S&P 500 |
| Last Week (6/28 - 7/5) | 0.27% | 1.98% |
| MTD | 0.27% | 1.98% |
| QTD | 0.27% | 1.98% |
| YTD | 10.53% | 17.57% |
| 1 Year | 21.67% | 27.10% |
| 5 Year | 8.86% | 15.11% |
| 10 Year | 7.62% | 12.93% |
| Inception (annualized since 6/26/00) | 7.30% | 7.77% |
Source: Bloomberg, Patient Capital Management.
The market rose to new all-time highs throughout the week on the back of weakening macro data with the unemployment rate reaching 4.1%, 0.7% above the cyclical trough. Tech stocks continued to lead the way with Meta Platforms, Inc. (META), Alphabet Inc. (GOOGL), and Amazon.com, Inc. (AMZN) reaching new all-time highs. The names benefited from a slew of price target increases. Raymond James increased their price target on Meta to $600 from $550, (upside of 11%). Canaccord increased their price target on Alphabet and Amazon to $220 and $230, respectively (upside of 15%).
S4 Capital plc (SFOR LN) rose through the 50-day, 100-day, and 200-day moving averages on limited news.
Alibaba Group Holding Ltd (BABA) rose after announcing they repurchased $5.8B in shares during the second quarter. (~3% of the current market cap).
Exhibit 2: Significant2 Contributors to Opportunity Equity Representative Account Performance, 6/28/24 - 7/5/24
| Name | Type | Net Return |
| S4 Capital plc | Equity | 29.2% |
| Meta Platforms, Inc. | Equity | 7.1% |
| Alphabet Inc. | Equity | 4.6% |
| Amazon.com, Inc. | Equity | 3.5% |
| Alibaba Group Holding Ltd | Equity | 3.5% |
Source: Patient Capital Management. See below for additional information.
Norwegian Cruise Line Holdings Ltd. (NCLH) fell through the 100-day moving average as concerns over Hurricane Beryl increased.
Precigen, Inc. (PGEN) fell through the 50-day and 100-day moving average. Shareholders approved an amendment allowing the company to issue 2M additional shares. (<1% shares outstanding).
Delta Air Lines, Inc. (DAL) fell through the 100-day moving average. Cowen increased their price target from $55 to $61 (32% upside).
OneMain Holdings, Inc. (OMF) fell on a Wells Fargo report that Branch traffic hit a record low showing a sharp decline in June. The decline resulted in the lowest foot traffic in June since 2017.
CVS Health Corp (CVS) fell on limited news.
Exhibit 3: Significant2 Detractors from Opportunity Equity Representative Account Performance, 6/28/24 - 7/5/24
| Name | Type | Net Return |
| Norwegian Cruise Line Holdings Ltd. | Equity | -7.0% |
| Precigen, Inc. | Equity | -10.1% |
| Delta Air Lines, Inc. | Equity | -3.0% |
| OneMain Holdings, Inc. | Equity | -2.4% |
| CVS Health Corp | Equity | -4.1% |
Source: Patient Capital Management. See below for additional information.
As of prior week's market close unless otherwise stated.
1The performance figures for the representative Opportunity Equity account reflect the deduction investment management fees and certain other expenses. Returns greater than 1 year are annualized.
Patient Capital Management, LLC completed its acquisition of the Opportunity Equity Strategy from Miller Value Partners, LLC on May 26, 2023. Patient Capital Management served as the investment adviser to the Opportunity Equity Strategy for the majority of the week referenced herein. Additionally, prior versions of this weekly blog posting refer to Miller Value Partners as investment adviser to the Opportunity Equity Strategy.
For additional information about Opportunity Equity Strategy performance, please click on the Opportunity Equity Strategy Composite Performance Disclosure. Past performance is no guarantee of future results.
2Significant Contributors and Detractors are based on holdings that had the greatest effect on representative account performance for the week. Holdings that have been in the portfolio since the end of the most recent calendar quarter are identified by name. The net return shown above for each individual security represents the change in market price of the security during the week, according to a third-party pricing service, or for the partial period held in the portfolio during the week. Net returns also include any purchases or sales that were made during the week. For information on how Contributor/Detractor data were calculated and a list showing the contribution to the Strategy’s weekly performance of each investment held at such quarter end, contact us.
Any views expressed are subject to change at any time, and Patient Capital Management disclaims any responsibility to update such views. There is no guarantee that market trends discussed herein will continue. The information presented should not be considered a recommendation to purchase or sell any security and should not be relied upon as investment advice. It should not be assumed that any purchase or sale decisions will be profitable or will equal the performance of any security mentioned. Past performance is no guarantee of future results, and there is no guarantee dividends will be paid or continued. References to specific securities are for illustrative purposes only. Portfolio composition is shown as of a point in time and is subject to change without notice. Content may not be reprinted, republished or used in any manner without written consent from Patient Capital Management.
©2024 Patient Capital Management, LLC
Share